SCHEMBL7909736

SCHEMBL7909736

CCCS(=O)(=O)NC1CC(C)(C)Oc2ccc(OCC(=O)NCCO)cc21

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 11/20 0.47
KDM4E B2RXH2 9/20 0.47
HPGD P15428 6/20 0.47
MEN1 O00255 1/20 0.47
KMT2A Q03164 1/20 0.47
NPSR1 Q6W5P4 1/20 0.47
GAA P10253 6/20 0.43
GLA P06280 3/20 0.43
MAPT P10636 2/20 0.40
HTT P42858 1/20 0.40
TAAR1 Q96RJ0 1/20 0.40
LMNA P02545 2/20 0.39
SMN1; SMN2 Q16637 2/20 0.39
HSD17B10 Q99714 5/20 0.39
CASP1 P29466 3/20 0.39
RAB9A P51151 1/20 0.39
TRPV1 Q8NER1 1/20 0.37
TSHR P16473 2/20 0.37
POLB P06746 1/20 0.37
CASP7 P55210 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7908101 0.91 ALDH1A1 (0.45) ALDH1A1KDM4EHPGDMEN1KMT2A
SCHEMBL7906977 0.91 CNR2 (0.41) ALDH1A1KDM4EHPGDMEN1KMT2A
SCHEMBL7910522 0.86 KCNE1 (0.43) ALDH1A1MEN1KMT2AMAPTHTT
SCHEMBL7910178 0.80 KCNE1 (0.42) ALDH1A1KDM4EHPGDGAAGLA
SCHEMBL6601917 0.79 ALDH1A1 (0.45) ALDH1A1KDM4EHPGDMEN1KMT2A
SCHEMBL7900359 0.79 KCNE1 (0.41) ALDH1A1KDM4EHPGDGAAMAPT
SCHEMBL7913688 0.76 CTSD (0.36) ALDH1A1KDM4EHPGDGAAGLA
SCHEMBL7910164 0.74 SIRT2 (0.39) ALDH1A1KDM4EHPGDMEN1KMT2A
SCHEMBL6559382 0.74 MAPT (0.45) ALDH1A1MEN1KMT2AGAAMAPT
SCHEMBL7464900 0.73 KCNE1 (0.52) ALDH1A1KDM4EHPGDMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6177449-B1 CARDIOVASCULAR DISORDERS; ANTIULCER AGENTS AVENTIS PHARMA DEUTSCHLAND GMBH (DE) 2001-01-23 US disclosed